A First in Human Study to Evaluate the Safety, Tolerability and PK of GB1211 in Healthy Subjects

Clinical trial NCT03809052 · COMPLETED

Trial details

NCT number: NCT03809052
Sponsor: Galecto Biotech AB
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety and Tolerability

Start date: 2019-01-14
Primary completion: 2019-06-25
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.